Wave Life Sciences Ltd.WVEEarnings & Financial Report
BIT Life Sciences is a for profit meetings, incentives, conferencing, exhibitions (MICE) company based in Dalian, China, that specializes in arranging multiple scientific congresses that have been described as "predatory". The company is part of a wave of organizations that have appeared in China in the past several years noted for arranging congresses with little academic merit and with the primary aim of generating revenue rather than scientific knowledge sharing. Papers submitted are usual...
WVE Q2 2025 Key Financial Metrics
Revenue
$8.7M
Gross Profit
N/A
Operating Profit
$-52.8M
Net Profit
$-50.5M
Gross Margin
N/A
Operating Margin
-606.5%
Net Margin
-580.2%
YoY Growth
-55.8%
EPS
$-0.31
Financial Flow
Wave Life Sciences Ltd. Q2 2025 Financial Summary
Wave Life Sciences Ltd. reported revenue of $8.7M for Q2 2025, with a net profit of $-50.5M (-580.2% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $8.7M |
|---|---|
| Net Profit | $-50.5M |
| Gross Margin | N/A |
| Operating Margin | -606.5% |
| Report Period | Q2 2025 |
Wave Life Sciences Ltd. Annual Revenue by Year
Wave Life Sciences Ltd. annual revenue history includes year-by-year totals (for example, 2023 revenue was $113.3M).
| Year | Annual Revenue |
|---|---|
| 2023 | $113.3M |
| 2022 | $3.6M |
Income Statement
| Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q1 2025 | Q2 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.9M | $22.1M | $49.2M | $29.1M | $12.5M | $19.7M | $9.2M | $8.7M |
| YoY Growth | 638.8% | 5794.9% | 17168.1% | 2245.1% | -3.0% | -10.9% | -26.8% | -55.8% |
Balance Sheet
| Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q1 2025 | Q2 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $267.3M | $230.0M | $199.9M | $274.9M | $235.3M | $208.8M | $288.3M | $252.4M |
| Liabilities | $294.1M | $273.8M | $232.5M | $227.4M | $202.0M | $204.4M | $108.7M | $105.2M |
| Equity | $-34.7M | $-51.7M | $-40.5M | $39.6M | $25.4M | $-3.5M | $171.8M | $139.3M |
Cash Flow
| Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q1 2025 | Q2 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $85.5M | $-37.3M | $-34.5M | $-33.2M | $-33.4M | $-27.5M | $-63.0M | $-46.0M |